Perioperative Complications following Artificial Urinary Sphincter Placement

The Journal of Urology
Brian J LinderD S Elliott

Abstract

We evaluated perioperative complications in patients undergoing primary artificial urinary sphincter placement and the potential impact of these complications on device outcomes. During the 2-year period from 2012 to 2014 we retrospectively evaluated the outcomes of 197 consecutive artificial urinary sphincter implantation procedures performed at our institution for post-prostatectomy incontinence. Of these cases 100 that were primary implantations comprise the study cohort. Perioperative complications, defined as those occurring within 6 weeks postoperatively, were classified by the Clavien-Dindo classification. After office evaluation at 6 weeks patients were followed for symptoms. Patient followup was obtained through office examination and telephone correspondence. Patients undergoing primary artificial urinary sphincter implantation had a median age of 71.5 years (IQR 66, 76). The overall rate of any complication (Clavien I-V) within 6 weeks of surgery was 35%, including urinary retention in 31% of cases, cellulitis in 1%, device infection in 2% and urethral erosion in 2%. No significant differences in pertinent clinical comorbidities such as age (p = 0.69), hypertension (p = 0.95), coronary artery disease (p = 0.57), diab...Continue Reading

Associated Clinical Trials

References

Mar 1, 1995·British Journal of Urology·F E Martins, S D Boyd
Mar 11, 2005·The Journal of Urology·Ganesh V RajGeorge D Webster
Jul 30, 2009·Annals of Surgery·Pierre A ClavienMasatoshi Makuuchi
Dec 12, 2012·European Urology·Frank Van der AaUNKNOWN Young Academic Urologists Functional Urology Group

❮ Previous
Next ❯

Citations

Feb 5, 2016·Urology·Oscar A Suarez, Kurt A McCammon
Apr 12, 2016·Neurourology and Urodynamics·X BiardeauJ Corcos
Sep 18, 2016·Biomechanics and Modeling in Mechanobiology·Arturo Nicola NataliWalter Artibani
Oct 5, 2017·Revista da Associação Médica Brasileira·UNKNOWN Brazilian Society of Urology (SBU)Wanderley Marques Bernardo
Jun 26, 2018·The Journal of Urology·Sidney B RadomskiSender Herschorn
Jan 16, 2018·Investigative and Clinical Urology·S Mitchell HeinerDaniel S Elliott
Mar 28, 2020·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alexander KretschmerUNKNOWN Debates On Male Incontinence (DOMINO)-Project
May 7, 2020·International Braz J Urol : Official Journal of the Brazilian Society of Urology·André Cavalcanti, Alex Schul
Feb 25, 2017·Current Urology Reports·Amy D Dobberfuhl, Craig V Comiter
Aug 28, 2020·Journal of Community Hospital Internal Medicine Perspectives·Ali Ahmad, Halina Kusz
Nov 18, 2020·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Ziye HuangJiongming Li
Mar 28, 2021·World Journal of Urology·Jordan NasriXavier Biardeau
Mar 30, 2021·Current Urology Reports·Roger K KhouriSteven J Hudak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.